$Esperion Therapeutics (ESPR.US)$Esperion Therapeutics (ESPR): A High-Growth Opportunity with Potential 10x Returns Esperion Therapeutics (ESPR), currently trading under $2 per share, has been attracting considerable attention from analysts. Recently, three analysts reaffirmed strong "Buy" ratings, with price targets ranging from $5 to $16 per share. Among the nine analysts covering Esperion, seven h...
$Clover Health (CLOV.US)$this will run up a good amount next week considering it’s going to finish above four. No one will be doing covered calls next week lol
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
HH1000 : but but this is lunr
Growth Investor27 HH1000 : $Esperion Therapeutics (ESPR.US)$ To the Moon. It has been sold hort & forced lower before an offer comes
HH1000 Growth Investor27 : i bought some calls for earnings a little while back. will see how that goes
72792912 : I no longer believe any positive rumors about this company
Rich2023 : Every day, some baseless rumors are spread.